MUC16 and neoplasm: Muc1-Bi antibodies recruit NK cells to drive effective and specific cell killing of MUC1-overexpressed tumor cells [84].Therefore, we hypothesized that bifocal antibodies targeting both MUC16 and CD16 would have similar effects in tumors.